Wells Fargo Investment Institute Report: Transformative Technologies
The Wells Fargo Investment Institute (WFII) has released a report titled Transformative Technologies: Investment Opportunities in Artificial Intelligence and Genomics. The report details how AI and genomics are reshaping investment landscapes and includes sections on AI's evolution, CRISPR technology, and practical investment strategies. WFII maintains a favorable outlook on Information Technology and Health Care sectors while offering insights into various investment vehicles, including mutual funds and private placements.
- The report highlights significant investment opportunities in AI and genomics, which are anticipated to shape the future economic landscape.
- WFII offers practical portfolio guidance from specialized teams, aiding investors in navigating these transformative technologies.
- A favorable outlook on Information Technology and Health Care sectors indicates potential growth areas for investors.
- Alternative investments, such as private equity funds, carry high risks and are suitable only for accredited investors.
- Investments in equity securities are subject to market risk, with potential volatility especially in small-cap stocks.
- Sector-focused investments may lead to increased portfolio volatility due to concentration in specific economic developments.
New report outlines investment opportunities in artificial intelligence and genomics
(Photo:
“Artificial intelligence (AI) and genomics have become more common and have the potential to influence not only how we live our lives, but also many sectors of the global economy in which we work and invest,” said
The report is broken down into three main sections to help investors understand how technology may impact the global economy over the next decade:
- The age of AI: Explains the origins and types of AI, machine learning, and neutral networks, as well as the key applications of AI today and in the future.
- CRISPR and the genomics revolution: Discusses the evolution of gene therapy to gene editing through the discovery of CRISPR (clustered regulatory interspaced short palindromic repeat), and how genomics has become a critical tool in possibly treating and preventing cancer and other diseases and conditions.
-
Investing in AI and genomics: Includes practical portfolio guidance from WFII’s Global Investment Strategy,
Global Securities Research , andGlobal Manager Research teams.
WFII has a favorable view on Information Technology and Health Care, which can benefit from developments in AI and genomics and believes that Communication Services, Financials, and Industrials — WFII has a neutral view on all three — can also benefit. Its analysts believe that there is a broad variety of investment options from technology-focused mutual funds and exchange-traded funds (ETFs) to private placements available to qualified investors.
Risk considerations
Alternative investments, such as private equity funds are not appropriate for all investors and are only open to “accredited” or “qualified” investors within the meaning of
Alternative investments, such as private equity funds, are speculative and involve a high degree of risk that is appropriate only for those investors who have the financial sophistication and expertise to evaluate the merits and risks of an investment in a fund and for which the fund does not represent a complete investment program. They entail significant risks that can include losses due to leveraging or other speculative investment practices, lack of liquidity, volatility of returns, restrictions on transferring interests in a fund, potential lack of diversification, absence and/or delay of information regarding valuations and pricing, complex tax structures and delays in tax reporting, less regulation and higher fees than mutual funds. Private equity fund investing involves other material risks including capital loss and the loss of the entire amount invested. A fund's offering documents should be carefully reviewed prior to investing.
All investing involves risks, including the possible loss of principal. There can be no assurance that any investment strategy will be successful. Investments fluctuate with changes in market and economic conditions and in different environments due to numerous factors, some of which may be unpredictable. Each asset class has its own risk and return characteristics. The level of risk associated with a particular investment or asset class generally correlates with the level of return the investment or asset class might achieve.
Equity securities are subject to market risk, which means their value may fluctuate in response to general economic and market conditions and the perception of individual issuers. Investments in equity securities are generally more volatile than other types of securities. The prices of small-cap stocks are generally more volatile than large company stocks. They often involve higher risks because smaller companies may lack the management expertise, financial resources, product diversification and competitive strengths to endure adverse economic conditions.
Sector investing can be more volatile than investments that are broadly diversified over numerous sectors of the economy and will increase a portfolio's vulnerability to any single economic, political, or regulatory development affecting the sector. This can result in greater price volatility.
Exchange-traded funds (ETFs) seek investment results that, before expenses, generally correspond to the price and yield of a particular index. There is no assurance that the price and yield performance of the index can be fully matched. ETFs are subject to substantially the same risks as individual ownership of the securities would entail. Investment returns may fluctuate and are subject to market volatility, so that an investor's shares, when redeemed or sold, may be worth more or less than their original cost.
About
Additional information may be found at www.wellsfargo.com | Twitter: @WellsFargo.
Cautionary Statement about Forward-Looking Statements
This news release contains forward-looking statements about our future financial performance and business. Because forward-looking statements are based on our current expectations and assumptions regarding the future, they are subject to inherent risks and uncertainties. Do not unduly rely on forward-looking statements as actual results could differ materially from expectations. Forward-looking statements speak only as of the date made, and we do not undertake to update them to reflect changes or events that occur after that date. For information about factors that could cause actual results to differ materially from our expectations, refer to our reports filed with the
News Release Category: WF-ERS
View source version on businesswire.com: https://www.businesswire.com/news/home/20220426005466/en/
Media
Sarah.Kerr@wellsfargo.com
Source:
FAQ
What investment opportunities are highlighted in Wells Fargo's report about AI and Genomics?
How does the report from Wells Fargo suggest investing in AI and Genomics?
What is WFII's outlook on the Information Technology and Health Care sectors?
Are there risks associated with the investments suggested in Wells Fargo's report?